Company / Operating Income per Share
Cartesian Therapeutics, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.70
FY2025
5-year range
-$16.01 / -$0.03
FY2021-FY2025
Trend
+89.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-0.03 to $-1.70 over the past 2 years.
Based on SEC 10-K filings.
-1.70 in FY2025.
Declined from $-0.03 to $-1.70 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 89.4% year-over-year.
- Peak operating income per share was recorded in FY2023.
- Lowest operating income per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.70 | +89.4% |
| FY2024 | -$16.01 | -53200.5% |
| FY2023 | -$0.03 | +93.5% |
| FY2022 | -$0.46 | +5.3% |
| FY2021 | -$0.49 | +35.6% |
| FY2020 | -$0.75 | +73.5% |
| FY2019 | -$2.84 | +59.9% |
| FY2016 | -$7.09 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026